Welcome to our press and media reel, here you will find the latest company updates, announcements and research materials.
-
Cellestial Health Joins ET Capital Portfolio and Secures Strategic Support
27th of April 2026; Cambridge, UK Cellestial Health, a biopharmaceutical company developing a new class of drugs for Parkinsonβs which affects over 10 million people in…
-
Something Different at BioTrinity
The CEO of Cellestial Health Dr Nat Hastings put the usual polished business pitch aside at the BioUK‘s BioTrinity 2026 to discuss an important topic:…
-
One Nucleus Awards Gala
Last Thursday 19th of March brought the UK-wide life sciences ecosystem leaders together for a very special occasion of the #ONAwards26 celebration at No.11 Cavendish Square in London. It…
-
Preparing for Success
On 10th of March at Jesus College Cambridge, Sygnature Discovery held a seminar on ππ΅π°π³πͺπ¦π΄ π°π§ ππ³πΆπ¨ ππͺπ΄π€π°π·π¦π³πΊ ππΆπ€π€π¦π΄π΄, joined by the Cellestial team Nat…